Detalhe da pesquisa
1.
Don't forget cord blood in non-remission acute myeloid leukaemia!
Br J Haematol
; 201(1): 11-12, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36507800
2.
Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT).
Am J Hematol
; 96(1): 69-79, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33064301
3.
Timing of Post-Transplantation Cyclophosphamide Administration in Haploidentical Transplantation: A Comparative Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 26(10): 1915-1922, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645444
4.
Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin Lymphomas.
Biol Blood Marrow Transplant
; 26(12): 2299-2305, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32822845
5.
Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for T Cell Acute Lymphoblastic Leukemia: A Report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party.
Biol Blood Marrow Transplant
; 26(5): 936-942, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31926364
6.
Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT study.
Br J Haematol
; 188(5): 745-756, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31498883
7.
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT.
Haematologica
; 105(1): 47-58, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31537691
8.
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients.
BMC Cancer
; 20(1): 1140, 2020 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33234127
9.
Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: Risk of Graft Failure, Poor Graft Function, and Impact on Outcomes.
Biol Blood Marrow Transplant
; 25(7): 1395-1406, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30826463
10.
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers.
Biol Blood Marrow Transplant
; 25(12): 2514-2516, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31445184
11.
Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 25(9): 1810-1817, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31128326
12.
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party.
Cancer
; 125(1): 90-98, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30351488
13.
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma.
Blood
; 129(10): 1380-1388, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28073785
14.
Caspofungin for primary antifungal prophylaxis after T-cell-replete haploidentical stem cell transplantation with post-transplant cyclophosphamide.
Eur J Haematol
; 102(4): 357-367, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30672611
15.
Killer Cell Immunoglobulin-Like Receptor-Ligand Mismatch in Donor versus Recipient Direction Provides Better Graft-versus-Tumor Effect in Patients with Hematologic Malignancies Undergoing Allogeneic T Cell-Replete Haploidentical Transplantation Followed by Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant
; 24(3): 549-554, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29247781
16.
T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors.
Biol Blood Marrow Transplant
; 24(3): 627-632, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29197681
17.
HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison.
Biol Blood Marrow Transplant
; 24(7): 1449-1454, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29448057
18.
Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide.
Cancer
; 124(7): 1428-1437, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29360162
19.
Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working Party.
Br J Haematol
; 181(1): 86-96, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29468647
20.
The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation.
Haematologica
; 103(8): 1390-1402, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29700172